Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
752 |
|
| Actual shortage: | 21 (3%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 642 (85%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
98 (10%) |
|
Overdue reports |
2 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLARUS | 40MG | CAPSULE | Resolved | 2022-01-13 | 2022-04-13 | 152648 |
| CLARUS | 10MG | CAPSULE | Resolved | 2022-06-18 | 2022-09-01 | 163042 |
| CLARUS | 40MG | CAPSULE | Resolved | 2022-06-18 | 2022-09-01 | 163045 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-07-09 | 2024-09-24 | 232550 |
| CLARUS | 40MG | CAPSULE | Resolved | 2024-07-09 | 2024-09-24 | 232553 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-10-04 | 2024-11-18 | 239457 |
| CLARUS | 40MG | CAPSULE | Resolved | 2024-10-29 | 2025-03-26 | 241465 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-12-03 | 2025-01-07 | 244622 |
| CLARUS | 10MG | CAPSULE | Resolved | 2025-01-21 | 2025-03-31 | 248180 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2017-11-08 | 2018-05-31 | 28619 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2021-01-05 | 2021-02-03 | 130854 |
| CONTINGENCY ONE | 1.5MG | TABLET | Resolved | 2025-01-07 | 2025-02-05 | 246904 |
| ESME 21 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51450 |
| ESME 28 | 20MCG 100MCG | TABLET | Resolved | 2018-06-05 | 2018-07-05 | 51453 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2018-12-05 | 2019-03-06 | 68756 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-05-22 | 2019-05-29 | 84512 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2019-06-04 | 2019-06-19 | 85557 |
| FREYA 21 | 0.15MG 0.03MG | TABLET | Resolved | 2020-01-28 | 2020-05-06 | 104512 |
| FREYA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171506 |
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2017-11-03 | 2019-03-21 | 28041 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-SIMVASTATIN | 5MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94112 |
| MYLAN-SIMVASTATIN | 10MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94117 |
| MYLAN-SIMVASTATIN | 20MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94122 |
| MYLAN-SIMVASTATIN | 40MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94127 |
| MYLAN-SIMVASTATIN | 80MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94132 |
| MYLAN-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51618 |
| MYLAN-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51624 |
| MYLAN-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6814 |
| MYLAN-TELMISARTAN HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6819 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| MYLAN-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Discontinued | 2017-04-13 | 2018-02-15 | 6822 |
| MYLAN-VALSARTAN | 40MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20209 |
| MYLAN-VALSARTAN | 320MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20217 |
| MYLAN-VALSARTAN | 160MG | TABLET | Discontinued | 2017-08-24 | 2017-11-02 | 20284 |
| MYLAN-VALSARTAN | 80MG | TABLET | Discontinued | 2018-04-04 | 2018-07-04 | 44919 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6827 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6833 |
| MYLAN-VALSARTAN HCTZ | 25MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6836 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6841 |